Abstract
In a prospective, randomized, controlled trial, we compared sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile, granulocytopenic patients; 101 patients received sulbactam/cefoperazone (2 g/4 g every 12 hours) and 102 patients received imipenem (500 mg every 6 hours). Documented infections were present in 40% of patients treated with sulbactam/cefoperazone (40 of 101) and in 39% of patients receiving imipenem (40 of 102). The number of pretherapy gram-positive pathogens (52 isolates) was twice the number of pretherapy gram-negative pathogens (26 isolates). The overall favorable clinical response rates for sulbactam/cefoperazone (91 of 103 patients, or 88%) and imipenem (84 of 104 patients, or 81%) were similar. Both drugs were generally well tolerated. However, diarrhea occurred more often in patients treated with sulbactam/cefoperazone (31 of 101 patients, or 31%, vs. 15 of 102 patients, or 15%; P = .007), while seizures developed only in patients receiving imipenem (0 of 101 patients vs. 3 of 102 patients, or 3%). Superinfections developed in 16% of patients in both study groups but were infrequently caused by beta-lactam-resistant gram-negative bacilli (two cases with sulbactam/cefoperazone therapy and ...Continue Reading
References
Dec 1, 1991·Annals of Internal Medicine·D J WinstonR E Champlin
Aug 28, 1986·The New England Journal of Medicine·P A PizzoJ McKnight
Aug 21, 1986·The New England Journal of Medicine
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A G FreifeldR C Young
Citations
Sep 28, 2004·Indian Journal of Pediatrics·Aditya H GaurJerry L Shenep
Feb 22, 2011·Medical Oncology·Indranil GhoshArti Kapil
Nov 26, 2009·Folia Microbiologica·S M ShrivastavaM Chaudhary
Jul 24, 2002·International Journal of Antimicrobial Agents·Satoshi IshiharaTakashi Deguchi
May 3, 2003·International Journal of Antimicrobial Agents·Jean A Klastersky
Oct 3, 2003·International Journal of Antimicrobial Agents·Wang FuZhang Yingyuan
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J WinstonK J Tack
Jul 2, 2003·Drugs·Nelson LeeCyrus R Kumana
Apr 20, 2014·The Journal of Antimicrobial Chemotherapy·Joan P CannonShellee A Grim
May 29, 2003·Leukemia & Lymphoma·E JourdanA Sotto
Apr 1, 2011·Pharmacotherapy·April D MillerCharles L Bennett
Jan 11, 2013·Pediatric Hematology and Oncology·Metin DemirkayaMustafa Hacımustafaoglu
May 16, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A S Levin
Sep 28, 2014·The Journal of Antimicrobial Chemotherapy·Shachaf ShiberMical Paul
Mar 4, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Borja, A Herreras
Dec 14, 2005·The Journal of Antimicrobial Chemotherapy·Mical PaulLeonard Leibovici
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Mical PaulLeonard Leibovici
Oct 13, 2006·Current Opinion in Infectious Diseases·J Klastersky
Feb 23, 2020·Medicine·Shao-Huan LanHung-Jen Tang
Mar 19, 2011·Pediatric Hematology and Oncology·Hacı Ahmet DemirMünevver Büyükpamukçu